-

Nomi Health Powers No Cost, On-Site COVID-19 Testing at Gathering of 20,000 at Annual Silicon Slopes Summit This Week

OREM, Utah--(BUSINESS WIRE)--In collaboration with the Silicon Slopes Summit, direct healthcare company Nomi Health will host all on-site testing for attendees, especially those without proof of vaccination. The conference is expecting 20,000 attendees, including notable keynotes from Steve Ballmer, Tim Cook and Dwayne Wade.

Dates: October 13-14, 2021
Testing Hours: 7:00 A.M. – 4:00 P.M. MT
Location: Silicon Slopes Summit, Salt Palace Convention Center
Testing Eligibility: Any registered event attendee without proof of vaccination

The testing process is free, easy and rapid with results delivered within minutes of testing. The testing site will be set up directly inside the entrance of the Convention Center. Nomi Health is also a lead partner sponsor of the Summit, and will be exhibiting at booth T1.

“We’re thankful to Nomi Health for their partnership in allowing us to gather at the Summit as safely as possible,” said Clint Betts, CEO and president, Silicon Slopes. “Nomi has advanced the approach to community health here in our backyard, and we’re looking forward to dynamic discussions in the week ahead celebrating Utah’s role in innovations across industries.”

To date, Nomi Health has facilitated nearly half a million tests and more than 125,000 vaccines across the State. For more information, and to view open positions, visit www.nomihealth.com.

About Nomi Health

Nomi Health is a direct healthcare company focused on making healthcare actually work for those who buy it for their states, organizations and constituents. We’re a team of over 2,000--each actively working to connect buyers and healthcare providers directly to lower costs, deliver care solutions to all and rewire the health system to run in real time. From the front lines of COVID testing and vaccination serving over 10 million Americans and more than 40,000 patients each day, to building new ecosystems of buyers such as States and Counties without middlemen, Nomi delivers a solution for our nation’s leaders seeking to widen access to care while lowering cost of care. Visit us @NomiHealth and www.nomihealth.com.

Contacts

Jenny Olson
mPR, Inc. for Nomi Health
jenny@mpublicrelations.com
310-773-2568

Nomi Health


Release Versions

Contacts

Jenny Olson
mPR, Inc. for Nomi Health
jenny@mpublicrelations.com
310-773-2568

More News From Nomi Health

CerpassRx Launches AI Engine Powered By Waltz Health to Deliver Real-Time Savings and Spend Management for Specialty Drugs

DALLAS & CHICAGO--(BUSINESS WIRE)--CerpassRx, a leader in pharmacy benefit management (PBM), today announced the launch of the Intelligent Specialty Engine, an AI-enabled platform powered by Waltz Health to manage specialty drug spend. CerpassRx’s innovative approach includes real-time analytics and specialty spend management capabilities that drive significant cost savings, improve transparency and optimize the specialty drug experience for health plan customers and their members – or self-ins...

CareSource and Nomi Health Launch Innovative Partnership to Improve Healthcare Access and Outcomes

DAYTON, Ohio--(BUSINESS WIRE)--CareSource, a non-profit health plan with over 2 million members, has selected Nomi Health to partner with it in launching a new comprehensive effort to help close gaps in healthcare access and outcomes for its Medicaid members across Ohio, Georgia, and Indiana. This collaboration aims to enhance access to essential healthcare services and improve overall health outcomes for people facing barriers to care. "This partnership with Nomi Health represents a significan...

Weight Loss Drugs Weigh Heavy on Employer Health Plans

OREM, Utah--(BUSINESS WIRE)--A meteoric rise in the popularity of glucagon-like peptide-1 (GLP-1) medications such as Ozempic, Wegovy and Mounjaro is creating financial challenges for employer-sponsored health plans. New data from Nomi Health, a company changing healthcare economics, reveals that spending on these diabetes and weight loss drugs went up 253% from 2020 to 2023, surpassing $1 billion last year and making up nearly 10% of total prescription costs for employers. Nomi Health analyzed...
Back to Newsroom